Ranitidine, 75 mg, over-the-counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro-oesophageal reflux.

Orenstein, S R; Blumer, J L; Faessel, H M; McGuire, J A; Fung, K; Li, B U K; Lavine, J E; Grunow, J E; Treem, W R; Ciociola, A A

Orenstein, S R; Blumer, J L; Faessel, H M; McGuire, J A; Fung, K; Li, B U K; Lavine, J E; Grunow, J E; Treem, W R; Ciociola, A A.

Affiliation

Orenstein SR; Pediatric Gastroenterology, Children's Hospital of Pittsburgh, Pittsburgh, PA 15213, USA. ORENSTS@CHPLINK.CHP.EDU

Aliment Pharmacol Ther ; 16(5): 899-907, 2002 May.

Article in En | MEDLINE | ID: mdl-11966498

Subject(s)

Anti-Ulcer Agents; Gastroesophageal Reflux/drug therapy; Ranitidine; Anti-Ulcer Agents/pharmacokinetics; Anti-Ulcer Agents/pharmacology; Anti-Ulcer Agents/therapeutic use; Area Under Curve; Child; Child, Preschool; Double-Blind Method; Female; Half-Life; Humans; Hydrogen-Ion Concentration; Male; Ranitidine/pharmacokinetics; Ranitidine/pharmacology; Ranitidine/therapeutic use

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ranitidine / Gastroesophageal Reflux / Anti-Ulcer Agents Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Child / Child, preschool / Female / Humans / Male Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2002 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links